taletrectinib
innovent biologics,baoyuan biopharma
['taletrectinib', '$ivbiy', 'innovent']
$ivbiy innovent and anheart jointly present updated phase 2 efficacy and safety data of taletrectinib (ros1-tki) at the 2022 american society of clinical oncology (asco) annual meeting 